• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen.

作者信息

Takami Akiyoshi, Chuhjo Tatsuya, Nakao Shinji

出版信息

Haematologica. 2002 Jun;87(6):659-61.

PMID:12031925
Abstract
摘要

相似文献

1
Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen.慢性粒细胞白血病（CML）慢性期采用白消安加环磷酰胺方案进行异基因骨髓移植后发生淋巴细胞危象的CML复发。
Haematologica. 2002 Jun;87(6):659-61.
2
Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.采用大剂量白消安和环磷酰胺（BU-CY）作为预处理方案进行无关供者异基因骨髓移植。
Bone Marrow Transplant. 1996 May;17(5):685-9.
3
Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.白消安、环磷酰胺及全身照射作为急性和慢性髓系白血病异基因骨髓移植的预处理方案
Bone Marrow Transplant. 1998 Jun;21(11):1079-83. doi: 10.1038/sj.bmt.1701244.
4
[Allogeneic bone marrow transplantation in myeloid leukemia: chemical conditioning, clinical course and results].[异基因骨髓移植治疗髓系白血病：化学预处理、临床过程及结果]
Acta Haematol Pol. 1992;23(2 Suppl 1):49-59.
5
Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia.噻替派、白消安和环磷酰胺作为晚期慢性粒细胞白血病异基因移植的预处理方案。
Bone Marrow Transplant. 1999 May;23(10):977-81. doi: 10.1038/sj.bmt.1701764.
6
Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset.
Bone Marrow Transplant. 2003 Feb;31(3):211-3. doi: 10.1038/sj.bmt.1703820.
7
Busulfan/cyclophosphamide plus bone marrow transplantation is not sufficient to eradicate the malignant clone in juvenile chronic myelogenous leukemia.
Bone Marrow Transplant. 1990 May;5(5):353-6.
8
Allogeneic bone marrow transplantation following busulfan and 90 mg/kg of cyclophosphamide.
Bone Marrow Transplant. 1993 Dec;12(6):655-8.
9
Fate of chronic myeloid leukemia patients treated with allogeneic bone marrow transplantation or chemotherapy and/or interferon at a single center: long-term results.在单一中心接受异基因骨髓移植或化疗和/或干扰素治疗的慢性粒细胞白血病患者的转归：长期结果
Bone Marrow Transplant. 2002 Jan;29(1):1-8. doi: 10.1038/sj.bmt.1703323.
10
Treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation after preparation with busulfan and cyclophosphamide (BuCy2): an update.使用白消安和环磷酰胺（BuCy2）预处理后进行异基因骨髓移植治疗慢性粒细胞白血病：最新进展
Semin Oncol. 1993 Aug;20(4 Suppl 4):27-31; quiz 32.